May 20, 2026

Subsequent Treatment Strategies in RCC:How Relapse Timing Guides Clinical Decisions

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

Optimizing Duration of Immuno-Therapyin Metastatic Renal Cell Carcinoma– When to Treat, Paus or Stop

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

Overview of Nordic Clinical Trials

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

Adjuvant Treatment in RCC – Perspectives in the Nordics

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

What Can Patients Do to Improve Outcomes?

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

Cytoreductive Nephrectomy and Secondary Nephrectomy. To do or not and what is the Evidence. 4

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

Navigating the unclear in Non-clear cell RCC. 4

  • Webinars & Events
  • Time: 1 minute

May 20, 2026

Curative approach in oligometastatic disease-Patient Cases.

  • Webinars & Events
  • Time: 1 minute

May 14, 2026

Cytoreductive nephrectomy in advanced RCC – Clinical Praxis in Sweden

  • Webinars & Events
  • Time: 1 minute

May 14, 2026

Management of specific drug toxicities The Immunotoxicity Clinic.

  • Webinars & Events
  • Time: 1 minute

May 14, 2026

Optimal treatment for patients in favorable IMDCs risk groups

  • Webinars & Events
  • Time: 1 minute